Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Jan 30, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001213900-23-006193.pdf
0001213900-23-006193.rtf
0001213900-23-006193.xls
Jan 30, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001213900-23-006188.pdf
0001213900-23-006188.rtf
0001213900-23-006188.xls
Jan 30, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001213900-23-006184.pdf
0001213900-23-006184.rtf
0001213900-23-006184.xls
Jan 30, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001213900-23-006181.pdf
0001213900-23-006181.rtf
0001213900-23-006181.xls
Jan 27, 2023 SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
0001493152-23-002808.pdf
0001493152-23-002808.rtf
0001493152-23-002808.xls
Jan 26, 2023 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
0001062993-23-001417.pdf
0001062993-23-001417.rtf
0001062993-23-001417.xls
Jan 26, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001062993-23-001419.pdf
0001062993-23-001419.rtf
0001062993-23-001419.xls
Jan 25, 2023 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001213900-23-005022.pdf
0001213900-23-005022.rtf
0001213900-23-005022.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 25, 2023 425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
0001213900-23-005026.pdf
0001213900-23-005026.rtf
0001213900-23-005026.xls
Jan 25, 2023 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
0001213900-23-005085.pdf
0001213900-23-005085.rtf
0001213900-23-005085.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next ›
  • Last page Last »
Displaying 81 - 90 of 177 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer